BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 29921613)

  • 1. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial.
    Abt D; Hechelhammer L; Müllhaupt G; Markart S; Güsewell S; Kessler TM; Schmid HP; Engeler DS; Mordasini L
    BMJ; 2018 Jun; 361():k2338. PubMed ID: 29921613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: 2-yr Outcomes of a Randomised, Open-label, Single-centre Trial.
    Abt D; Müllhaupt G; Hechelhammer L; Markart S; Güsewell S; Schmid HP; Mordasini L; Engeler DS
    Eur Urol; 2021 Jul; 80(1):34-42. PubMed ID: 33612376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Obstruction: 5-year Outcomes of a Randomised, Open-label, Noninferiority Trial.
    Müllhaupt G; Hechelhammer L; Graf N; Mordasini L; Schmid HP; Engeler DS; Abt D
    Eur Urol Focus; 2024 Mar; ():. PubMed ID: 38531756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study).
    Ray AF; Powell J; Speakman MJ; Longford NT; DasGupta R; Bryant T; Modi S; Dyer J; Harris M; Carolan-Rees G; Hacking N
    BJU Int; 2018 Aug; 122(2):270-282. PubMed ID: 29645352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Comparison of Prostatic Artery Embolization versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia.
    Insausti I; Sáez de Ocáriz A; Galbete A; Capdevila F; Solchaga S; Giral P; Bilhim T; Isaacson A; Urtasun F; Napal S
    J Vasc Interv Radiol; 2020 Jun; 31(6):882-890. PubMed ID: 32249193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Reddy B; Shin TY; Kim MH; Narayan V; Dahm P
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012867. PubMed ID: 33368143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis.
    Carnevale FC; Iscaife A; Yoshinaga EM; Moreira AM; Antunes AA; Srougi M
    Cardiovasc Intervent Radiol; 2016 Jan; 39(1):44-52. PubMed ID: 26506952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostatic artery embolization versus conventional TUR-P in the treatment of benign prostatic hyperplasia: protocol for a prospective randomized non-inferiority trial.
    Abt D; Mordasini L; Hechelhammer L; Kessler TM; Schmid HP; Engeler DS
    BMC Urol; 2014 Nov; 14():94. PubMed ID: 25425136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised Clinical Trial of Prostatic Artery Embolisation Versus a Sham Procedure for Benign Prostatic Hyperplasia.
    Pisco JM; Bilhim T; Costa NV; Torres D; Pisco J; Pinheiro LC; Oliveira AG
    Eur Urol; 2020 Mar; 77(3):354-362. PubMed ID: 31831295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thulium laser transurethral vaporesection versus transurethral resection of the prostate for benign prostatic obstruction: the UNBLOCS RCT.
    Worthington J; Lane JA; Taylor H; Young G; Noble SM; Abrams P; Ahern A; Brookes ST; Cotterill N; Johnson L; Khan R; Fernandez AM; Page T; Swami S; Hashim H
    Health Technol Assess; 2020 Sep; 24(41):1-96. PubMed ID: 32901611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Kim MH; Narayan VM; Dahm P
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD012867. PubMed ID: 35349161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic Review and Meta-analysis Comparing Prostatic Artery Embolization to Gold-Standard Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia.
    Knight GM; Talwar A; Salem R; Mouli S
    Cardiovasc Intervent Radiol; 2021 Feb; 44(2):183-193. PubMed ID: 33078236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.
    Franco JV; Jung JH; Imamura M; Borofsky M; Omar MI; Escobar Liquitay CM; Young S; Golzarian J; Veroniki AA; Garegnani L; Dahm P
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013656. PubMed ID: 34693990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transurethral resection of the prostate versus prostatic artery embolization in the treatment of benign prostatic hyperplasia: a meta-analysis.
    Jiang YL; Qian LJ
    BMC Urol; 2019 Jan; 19(1):11. PubMed ID: 30691478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective observation of the efficacy and safety of prostatic artery embolization combined with transurethral resection of the prostate and simple transurethral resection of the prostate in the treatment of large (> 100 mL) benign prostatic hyperplasia.
    Tang Y; Wang RL; Ruan DD; Chen X; Zhou YF; Wu SJ; Cai SL; Zhang JH; Yang FG; Luo JW; Fang ZT
    Abdom Radiol (NY); 2021 Dec; 46(12):5746-5757. PubMed ID: 34448024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Utility Analysis of Prostatic Artery Embolization for Treatment of Lower Urinary Tract Symptoms.
    Capdevila F; Insausti I; San Miguel R; Sanchez-Iriso E; Montesino M
    Cardiovasc Intervent Radiol; 2023 Aug; 46(8):1025-1035. PubMed ID: 37142802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate--a prospective, randomized, and controlled clinical trial.
    Gao YA; Huang Y; Zhang R; Yang YD; Zhang Q; Hou M; Wang Y
    Radiology; 2014 Mar; 270(3):920-8. PubMed ID: 24475799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing prostatic artery embolization to surgical and minimally invasive procedures for the treatment of benign prostatic hyperplasia: a systematic review and meta-analysis.
    Altman R; Ferreira R; Barragan C; Bhojani N; Lajkosz K; Zorn KC; Chughtai B; Annamalai G; Elterman DS
    BMC Urol; 2024 Jan; 24(1):22. PubMed ID: 38281906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An updated meta-analysis of prostatic arterial embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia.
    Xu XJ; Li J; Huang XZ; Liu Q
    World J Urol; 2020 Oct; 38(10):2455-2468. PubMed ID: 31813027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial.
    Napal Lecumberri S; Insausti Gorbea I; Sáez de Ocáriz García A; Solchaga Álvarez S; Cebrián Lostal JL; Monreal Beortegui R; Giral Villalta PJ; Urtasun Grijalba F
    Res Rep Urol; 2018; 10():17-22. PubMed ID: 29492398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.